Basilea announces CHF 75 million senior secured loan agreement with Athyrium for non-dilutive refinancing of convertible bonds due in December 2022
Ad hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, September 07, 2022 Basilea Pharmaceutica…